Movement Alert｜Boston Scientific Falls 3.25% in Regular Trading, Multiple Investment Banks Cut Price Targets Amid Broad Sector Weakness

Market Focus07-14

On July 14, Boston Scientific fell 3.25% in regular trading, trading at $43.22/share, with turnover of $105 million.

On the news front, RBC Capital Markets on July 13 cut its price target on Boston Scientific from $100 to $85 while maintaining an Outperform rating. This follows a wave of downgrades from multiple investment banks in recent weeks. Needham cut its target from $77 to $57, Evercore ISI adjusted from $78 to $65, Jefferies reduced from $100 to $67, and Piper Sandler lowered from $90 to $65. The FactSet consensus mean price target has declined from approximately $86 in April to $72.42 currently.

The downgrades reflect ongoing concerns after CEO Mike Mahoney flagged short-term challenges in late May, citing flat sequential US revenue for the Watchman device and broader business headwinds. The company had previously lowered its full-year organic growth guidance to 6.5%-8%.

At the sector level, Health Care Equipment stocks declined broadly, with GE Healthcare down 5.67%, Stryker down 5.57%, Medtronic down 3.71%, Intuitive Surgical down 3.71%, and Abbott Laboratories down 2.70%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1146087066?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-14 22:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146087066","market":"us","top_or_hot":-1,"title":"Movement Alert｜Boston Scientific Falls 3.25% in Regular Trading, Multiple Investment Banks Cut Price Targets Amid Broad Sector Weakness","media":"Market Focus","content":"<p><p>On July 14, Boston Scientific fell 3.25% in regular trading, trading at $43.22/share, with turnover of $105 million.</p><p>On the news front, RBC Capital Markets on July 13 cut its price target on Boston Scientific from $100 to $85 while maintaining an Outperform rating. This follows a wave of downgrades from multiple investment banks in recent weeks. Needham cut its target from $77 to $57, Evercore ISI adjusted from $78 to $65, Jefferies reduced from $100 to $67, and Piper Sandler lowered from $90 to $65. The FactSet consensus mean price target has declined from approximately $86 in April to $72.42 currently.</p><p>The downgrades reflect ongoing concerns after CEO Mike Mahoney flagged short-term challenges in late May, citing flat sequential US revenue for the Watchman device and broader business headwinds. The company had previously lowered its full-year organic growth guidance to 6.5%-8%.</p><p>At the sector level, Health Care Equipment stocks declined broadly, with GE Healthcare down 5.67%, Stryker down 5.57%, Medtronic down 3.71%, Intuitive Surgical down 3.71%, and Abbott Laboratories down 2.70%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Boston Scientific Falls 3.25% in Regular Trading, Multiple Investment Banks Cut Price Targets Amid Broad Sector Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Boston Scientific Falls 3.25% in Regular Trading, Multiple Investment Banks Cut Price Targets Amid Broad Sector Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-14 22:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 14, Boston Scientific fell 3.25% in regular trading, trading at $43.22/share, with turnover of $105 million.</p><p>On the news front, RBC Capital Markets on July 13 cut its price target on Boston Scientific from $100 to $85 while maintaining an Outperform rating. This follows a wave of downgrades from multiple investment banks in recent weeks. Needham cut its target from $77 to $57, Evercore ISI adjusted from $78 to $65, Jefferies reduced from $100 to $67, and Piper Sandler lowered from $90 to $65. The FactSet consensus mean price target has declined from approximately $86 in April to $72.42 currently.</p><p>The downgrades reflect ongoing concerns after CEO Mike Mahoney flagged short-term challenges in late May, citing flat sequential US revenue for the Watchman device and broader business headwinds. The company had previously lowered its full-year organic growth guidance to 6.5%-8%.</p><p>At the sector level, Health Care Equipment stocks declined broadly, with GE Healthcare down 5.67%, Stryker down 5.57%, Medtronic down 3.71%, Intuitive Surgical down 3.71%, and Abbott Laboratories down 2.70%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSX","symbol_name":"波士顿科学","start_time":0,"source_url":"","article_id":"1146087066","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146087066","pubTimestamp":1784037696,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 14, Boston Scientific fell 3.25% in regular trading, trading at $43.22/share, with turnover of $105 million.On the news front, RBC Capital Markets on July 13 cut its price target on Boston...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BSX":"波士顿科学"},"translate_title":"走势警报|波士顿科学公司常规交易中下跌 3.25%，多家投资银行在整体行业疲软的情况下下调目标价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSX":1},"content_text":"On July 14, Boston Scientific fell 3.25% in regular trading, trading at $43.22/share, with turnover of $105 million.On the news front, RBC Capital Markets on July 13 cut its price target on Boston Scientific from $100 to $85 while maintaining an Outperform rating. This follows a wave of downgrades from multiple investment banks in recent weeks. Needham cut its target from $77 to $57, Evercore ISI adjusted from $78 to $65, Jefferies reduced from $100 to $67, and Piper Sandler lowered from $90 to $65. The FactSet consensus mean price target has declined from approximately $86 in April to $72.42 currently.The downgrades reflect ongoing concerns after CEO Mike Mahoney flagged short-term challenges in late May, citing flat sequential US revenue for the Watchman device and broader business headwinds. The company had previously lowered its full-year organic growth guidance to 6.5%-8%.At the sector level, Health Care Equipment stocks declined broadly, with GE Healthcare down 5.67%, Stryker down 5.57%, Medtronic down 3.71%, Intuitive Surgical down 3.71%, and Abbott Laboratories down 2.70%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1146087066","isCrawlerRequest":true}